About us|Cardiac Arrest|LUCAS CPR|For users|News & Media|Contact|

News archive

LUCAS at TCT08 – a primary choice for effective resuscitation in the cath lab

November 19, 2008, Lund, Sweden

At the world’s largest congress for interventional cardiologists – the TCT08 congress in Washington D.C., US – last month, three life-saving case-presentations demonstrated the benefits of using the LUCAS Chest Compression System in the catheterization laboratory. This was the second year in a row in which LUCAS received attention as a tool to enable safe and effective resuscitation in patients complicated by a cardiac arrest on the cath lab table.

LUCAS is currently used in several cardiac catheterization centers around Europe, and the cases presented this year came from Graz in Austria and Lund in Sweden. The LUCAS Chest Compression System is mainly radiotranslucent, which allows for visibility of the coronary arteries in most X-ray projections, as well as for a continued intervention during effective CPR. In addition, it increases personnel safety, as rescuers no longer have to compromise their own safety by being exposed to high doses of X-rays.

Dr. Jan Harnek, Director of the Cardiac Catheterization Laboratory at Lund University Hospital in Sweden, who presented two life-saving LUCAS cases, commented;
“Over the last four years, we have used the LUCAS device on several occasions in our cath lab. It allows us to continue the intervention with sustained circulation in the patient, despite the cardiac arrest. It is well known that manual CPR cannot be sufficiently maintained for more than two minutes, thus LUCAS is our primary choice in the event of a cardiac arrest. The device is applied immediately, taking only some 30 seconds to have it fully operating on the patient. LUCAS can maintain circulation for an unlimited period of time, better than any other device.”

Erik von Schenck, CEO of Jolife AB, the manufacturer and developer of the LUCAS device said;
“We are excited that LUCAS is being embraced by interventional cardiologists. Revascularization in the cath lab is a key therapy for acute myocardial infarction, a condition that risks develop into a sudden cardiac arrest. LUCAS has proven to be highly suitable for the cath lab, and as it is driven by air available in wall outlets, it can be operating without interruption during hours of simultaneous intervention. LUCAS offers a new standard for cath lab resuscitation, as manual CPR is almost impossible to provide effectively during intervention.”

The LUCAS™ Chest Compression System helps ambulance and hospital personnel to save patients suffering sudden cardiac arrest. The device performs continuous chest compressions to maintain blood flow to the brain and heart. International resuscitation guidelines issued in 2005 stress the importance of effective and uninterrupted chest compressions prior to defibrillation. LUCAS performs chest compressions in accordance with these guidelines, without risking quality variations or tiring out personnel. The device also allows safe transportation and simultaneous defibrillation and angiography.

About Jolife AB
Jolife is dedicated to increasing the survival chances of people suffering sudden cardiac arrest, and to increasing the number who survive with their quality of life intact. This is being achieved by leading research and development in the field, in order to offer innovative products that define the future treatment of sudden cardiac arrest. The company was founded in 2000 and has since worked closely with leading physicians and paramedics on research and development. This work has resulted in groundbreaking knowledge about the physiological effects of cardiac arrest and the importance of high-quality chest compressions. The LUCAS Chest Compression System is sold in the US, Europe and other parts of the world. Based in Lund in southern Sweden, Jolife markets its products through an exclusive global distribution agreement with Physio-Control, Inc., a division of Medtronic Ltd – except in Sweden, Norway and Finland, where Jolife sells direct. For more information, please visit www.jolife.com or www.lucas-cpr.com.

Further information:
Erik von Schenck, CEO, JOLIFE
Tel: +46 46 286 5002
Mobile: +46 733 147471
E-mail: evs@jolife.com

Jolife AB
Scheelevägen 17
223 70 Lund
Tel: +46 46 286 5000

Latest news
Train on LUCAS™

Physio-Control Inc. / Jolife AB, Ideon Science Park, SE-223 70 Lund, Sweden, Tel: +46 (0) 46 286 50 00, Fax: +46 (0) 46 286 50 10, info@lucas-cpr.com
Powered by Publiciteta&Co